Literature DB >> 17198937

Determinants of serum albumin concentration analyzed in a large cohort of patients on maintenance hemodialysis.

Stephan Thijssen1, Grzegorz Wystrychowski, Len Usvyat, Peter Kotanko, Nathan W Levin.   

Abstract

OBJECTIVE: Serum albumin concentration is a powerful predictor of mortality in patients on chronic hemodialysis (CHD). This study sought to investigate variables associated with serum albumin concentration. DESIGN AND STUDY POPULATION: Cross-sectional study in prevalent chronic hemodialysis patients treated at the Renal Research Institute between July 1, 2005 and October 31, 2005. A total of 4,798 (2,199 females) patients were studied. MAIN OUTCOME MEASURES: Univariate and multivariate relationships of serum albumin concentration with age, sex, race (black, white, other), vascular access type (arteriovenous fistula/graft, catheter), white blood cells, neutrophils, lymphocytes, equilibrated normalized protein catabolic rate (enPCR), dialysis efficacy (eKdrt/V), hemoglobin, phosphate, bio-intact parathyroid hormone [bioPTH], creatinine, alanine aminotransferase (ALT), and aspartate aminotransferase (AST).
RESULTS: Age, access type, and variables of 3 domains, namely, nutrition (enPCR; creatinine), eKdrt/V, and inflammation (white blood cells; neutrophil:lymphocyte ratio; hemoglobin), were related to serum albumin. It is interesting to note that AST was the strongest negative predictor of albumin levels.
CONCLUSION: In CHD patients, serum albumin concentration is defined by a complex interaction of inflammation, nutrition, and dialysis efficacy. The relationship between AST and albumin deserves additional study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198937     DOI: 10.1053/j.jrn.2006.10.011

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  7 in total

1.  The Mutual Contribution of 3-NT, IL-18, Albumin, and Phosphate Foreshadows Death of Hemodialyzed Patients in a 2-Year Follow-Up.

Authors:  Łukasz Kasprzak; Mateusz Twardawa; Piotr Formanowicz; Dorota Formanowicz
Journal:  Antioxidants (Basel)       Date:  2022-02-11

2.  Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.

Authors:  Nicole Schupp; Eva Maria Dette; Ursula Schmid; Udo Bahner; Michaela Winkler; August Heidland; Helga Stopper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-29       Impact factor: 3.000

3.  The insufficiency intake of dietary micronutrients associated with malnutrition-inflammation score in hemodialysis population.

Authors:  Jie Chen; Hongquan Peng; Kun Zhang; Long Xiao; Zhimin Yuan; Jianping Chen; Zhiyu Wang; Jingfeng Wang; Hui Huang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

4.  Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients.

Authors:  Jérôme Pineault; Caroline Lamarche; Robert Bell; Jean-Philippe Lafrance; Georges Ouellet; Martine Leblanc; Vincent Pichette; Sarah Bezzaoucha; Michel Vallée
Journal:  Can J Kidney Health Dis       Date:  2017-11-03

5.  Mineral and bone disorder and management in the China Dialysis Outcomes and Practice Patterns Study.

Authors:  Jun Wang; Brian A Bieber; Fan-Fan Hou; Friedrich K Port; Shuchi Anand
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

6.  Inflammation but not dietary macronutrients insufficiency associated with the malnutrition-inflammation score in hemodialysis population.

Authors:  Jie Chen; Hongquan Peng; Long Xiao; Kun Zhang; Zhimin Yuan; Jianping Chen; Zhiyu Wang; Jingfeng Wang; Hui Huang
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

7.  Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study.

Authors:  Nagaraja Rao Sridhar; Sowmya Josyula
Journal:  BMC Nephrol       Date:  2013-11-01       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.